[PDF][PDF] Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the …

J Boren, MJ Chapman, RM Krauss… - European heart …, 2020 - academic.oup.com
OP-EHEA191011_online 2313..2340 Page 1 Low-density lipoproteins cause atherosclerotic
cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus …

Antioxidant properties of anthocyanins and their mechanism of action in atherosclerosis

C Garcia, CN Blesso - Free Radical Biology and Medicine, 2021 - Elsevier
Atherosclerosis develops due to lipid accumulation in the arterial wall and sclerosis as result
of increased hyperlipidemia, oxidative stress, lipid oxidation, and protein oxidation …

Elimination of established tumors with nanodisc-based combination chemoimmunotherapy

R Kuai, W Yuan, S Son, J Nam, Y Xu, Y Fan… - Science …, 2018 - science.org
Although immune checkpoint blockade has shown initial success for various cancers, only a
small subset of patients benefits from this therapy. Some chemotherapeutic drugs have been …

Pathophysiology of human visceral obesity: an update

A Tchernof, JP Després - Physiological reviews, 2013 - journals.physiology.org
Excess intra-abdominal adipose tissue accumulation, often termed visceral obesity, is part of
a phenotype including dysfunctional subcutaneous adipose tissue expansion and ectopic …

Toll-like receptors: activation, signalling and transcriptional modulation

D De Nardo - Cytokine, 2015 - Elsevier
Abstract Families of innate immune receptors serve as the bodies primary defence system
by recognising and rapidly responding to infection by microorganisms or to endogenous …

Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study

M Jaiswal, J Divers, D Dabelea, S Isom, RA Bell… - Diabetes …, 2017 - Am Diabetes Assoc
OBJECTIVE We assessed the prevalence of and risk factors for diabetic peripheral
neuropathy (DPN) in youth with type 1 diabetes (T1D) and type 2 diabetes (T2D) enrolled in …

[HTML][HTML] High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease

CE Kosmas, I Martinez, A Sourlas, KV Bouza… - Drugs in …, 2018 - ncbi.nlm.nih.gov
Several prospective epidemiological studies have shown that there is a clear inverse
relationship between serum high-density lipoprotein-cholesterol (HDL-C) concentrations …

High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3

D De Nardo, LI Labzin, H Kono, R Seki… - Nature …, 2014 - nature.com
High-density lipoprotein (HDL) mediates reverse cholesterol transport and is known to be
protective against atherosclerosis. In addition, HDL has potent anti-inflammatory properties …

An abundant dysfunctional apolipoprotein A1 in human atheroma

Y Huang, JA DiDonato, BS Levison, D Schmitt, L Li… - Nature medicine, 2014 - nature.com
Recent studies have indicated that high-density lipoproteins (HDLs) and their major
structural protein, apolipoprotein A1 (apoA1), recovered from human atheroma are …

[HTML][HTML] Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease

C Besler, K Heinrich, L Rohrer… - The Journal of …, 2011 - Am Soc Clin Investig
HDL cholesterol activates endothelial cell production of the atheroprotective signaling
molecule NO, and it promotes endothelial repair. In this issue of the JCI, Besler et al. provide …